NVIV
InVivo Therapeutics Holdings Corporation
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
Richard M. Toselli
IPO Date
2010-11-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
InVivo Therapeutics Holdings Corporation
CEO
Richard M. Toselli
IPO Date
2010-11-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 61,000 |
| $0.00 |
| 21 Nov 2022 | ROBERTS RICHARD JOHN | director | A-Award | Acquired | 4,200 | $0.00 |
| 21 Nov 2022 | MARSHAK DANIEL R | director | A-Award | Acquired | 4,200 | $0.00 |
| 21 Nov 2022 | Morrison Christina | director | A-Award | Acquired | 4,200 | $0.00 |
| 21 Nov 2022 | ROSENTHAL BOB | director | A-Award | Acquired | 4,200 | $0.00 |
| 21 Nov 2022 | CHRISTOPHER RICHARD | Chief Financial Officer | A-Award | Acquired | 20,800 | $0.00 |
| 23 Dec 2021 | Toselli Richard M. | director, officer: See Remarks | F-InKind | Disposed | 16 | $0.54 |
| 23 Jun 2021 | Toselli Richard M. | director, officer: See Remarks | F-InKind | Disposed | 21 | $0.74 |
| 22 Mar 2021 | MERRIFIELD C ANN | director | A-Award | Acquired | 15,000 | $1.10 |